Organisation paid for research Program year 2025 Source: CMS Open Payments

S2m2 Enterprises LLC

Neither a doctor nor a teaching hospital

Research payments

$699,909

72 payments

Through program year 2025, S2m2 Enterprises LLC is reported as receiving $699,909 in research payments, across 72 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $132,770 19
2024 Research $150,110 27
2023 Research $417,030 26

Breakdown

Who paid Research payments · program years 2023–2025
  1. Genentech, Inc. $699,909 72 payments
Studies the money was for Research payments · program years 2023–2025
  1. Roche Cancer Screening Collection Study $603,508 52 payments
  2. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis (Ametrine-2) $44,611 11 payments
  3. Rvt-3101-201 (Tahoe) $32,540 2 payments
  4. PH III Study to Evaluate the Efficacy and Safety of Astegolimab in COPD $19,250 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record